发明公开
EP2027123A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS 有权
化合物和组合物作为蛋白激酶抑制剂

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
摘要:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the AbI, Bcr-Abl, Bcr-Abl(T315I), ALK5BLK, BMX, BRK, C-kit, c-RAF, CSK, c-SRC, EGFR, Fes, FGFR3, Flt3, Fms, Fyn, IGF-IR, IR, JAK(2), JAK(3), KDR, Lck, NLK, p70S6K, PDGFRα, Ros, SAPK2α, SGK, SIK, Syk, Tie2 and TrkB kinases.
公开/授权文献
信息查询
0/0